drugset / Trial / NCT06148168

Magnesium Sulphate in Oblique Subcostal TAP Block

NCT06148168

Phase 2/3 Unknown 72 enrolled Assiut University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to evaluate the effect of adding different doses of MgSO4 to bupivacaine via OSCTAB block on postoperative pain control for 24 hours in patients scheduled for LC.

Timeline

Start
2024-01-01
Primary completion
2025-01-20
Completion
2025-02-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 250 mg Other
Comparator Magnesium Sulfate Other / unclassified 500 mg Other
Comparator Bupivacaine Other / unclassified 0.25 % Other

Indications

No indication recorded.